JOIN US FOR THE 2026 EDUCATION & SUPPORT CONFERENCE!

Courtney Bugler is a trailblazing nonprofit executive with extensive experience in leading national health charities to advance program development, organizational infrastructure, fundraising, and advocacy. As the CEO and President of ZERO Prostate Cancer, she brings a strong track record of success and a deep commitment to advancing the organization's mission. 

Prior to her appointment at ZERO Prostate Cancer, Courtney served as the Chief Development and Marketing Officer at the Piedmont Park Conservancy. Courtney played a pivotal role in elevating the organization's profile and expanding its philanthropic efforts despite the challenges posed by the global pandemic. Throughout her career, Courtney has been passionate about driving systemic progress in public health to save lives. Previously, she spearheaded substantial organizational change and growth as the National Director of the Race for the Cure / MORE THAN PINK Walk Series at Susan G. Komen, leading a nationwide affiliated staff of 200 to successfully transform a top-ten National Peer-to-Peer Walk Series. While at Komen, she led the rollout of a new brand and restructured a support team of fundraisers to drive a yearly revenue budget of nearly $50 million. She has also held notable positions at JDRF International and the Young Survival Coalition, where she made significant contributions to fundraising, program development, and organizational expansion. 

Courtney is a highly trained consumer advocate with more than fifteen years of expertise in cancer, healthy equity, chronic disease management, and public health communications. She is certified and trained in patient navigation, cancer survivor support modules and facilitation, as well as grant review and evaluation. She has lobbied on Capitol Hill for more than a billion dollars in funding toward the Department of Defense Congressionally Directed Medical Research Program and has served as a consumer advocate research grant reviewer for that same program. 

Courtney has researched, written, and developed some of the most successful programs and health communication tools for young women with breast cancer and at-risk populations through her work with the Young Survival Coalition and the state of Georgia. Courtney is an outstanding presenter and dynamic public speaker, addressing hundreds of thousands of people live and through media on disparities in cancer care and access, cancer survivorship, and psychosocial support needs. She holds a Bachelor's degree in Communications from Northwestern University and is a Certified Fundraising Executive®.

As a caregiver to her father, who currently lives with prostate cancer, and a seventeen-year cancer survivor herself, Courtney is honored to be at the forefront of the fight against prostate cancer. Courtney lives in Atlanta, GA, with her son and two rescue dogs.

Brian Bragg serves as ZERO Prostate Cancer's Chief Mission Officer. He is a seasoned healthcare leader with over 20 years of progressive leadership experience in public health and health promotion. He has specific expertise in community and population health and health systems integration. 

As Chief Mission Officer, Brian is leading a comprehensive approach, working both in-community and virtually to accelerate and expand mission delivery. One of his top priorities is to build capabilities in interventions, outreach, and health programs across the prostate cancer continuum, piloted in underserved communities to drive nationwide health equity impacts. He’s also driving volunteer efforts and collaborative partnerships with organizations on the ground to best serve those impacted by prostate cancer at the local level. 

With decades of extensive leadership experience, Brian has dedicated his career to ensuring communities have access to quality health care and building programs that promote health equity. For more than 24 years, he’s served in leadership positions overseeing health initiatives at Access Community Health Network (ACCESS) in Chicago, one of the largest Federally Qualified Health Centers (FQHCs) in the United States. Most recently, as the Vice President of Health Equity, Brian advanced critical programs in primary care, behavioral health, and infectious disease with a focus on addressing health disparities.

Brian Bragg serves as ZERO Prostate Cancer's Chief Mission Officer. He is a seasoned healthcare leader with over 20 years of progressive leadership experience in public health and health promotion. He has specific expertise in community and population health and health systems integration. 

As Chief Mission Officer, Brian is leading a comprehensive approach, working both in-community and virtually to accelerate and expand mission delivery. One of his top priorities is to build capabilities in interventions, outreach, and health programs across the prostate cancer continuum, piloted in underserved communities to drive nationwide health equity impacts. He’s also driving volunteer efforts and collaborative partnerships with organizations on the ground to best serve those impacted by prostate cancer at the local level. 

With decades of extensive leadership experience, Brian has dedicated his career to ensuring communities have access to quality health care and building programs that promote health equity. For more than 24 years, he’s served in leadership positions overseeing health initiatives at Access Community Health Network (ACCESS) in Chicago, one of the largest Federally Qualified Health Centers (FQHCs) in the United States. Most recently, as the Vice President of Health Equity, Brian advanced critical programs in primary care, behavioral health, and infectious disease with a focus on addressing health disparities.

Dr. Kelvin A. Moses is an Assistant Professor of Urologic Surgery at Vanderbilt University Medical Center and director of the Comprehensive Prostate Cancer Clinic. His clinical practice focuses on advanced prostate cancer, including conducting several clinical trials and surgical management of advanced renal and testicular cancer. His work focuses on addressing health disparities in urologic cancers, determining the role of health literacy in patient interactions with the health care system, and optimal care for patients with metastatic and/or castrate-resistant prostate cancer. Dr. Moses also sits on ZERO’s Medical Advisory Board.

Daniel M. Geynisman, MD, is an Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center and the Division Chief of Genitourinary Medical Oncology, as well as the Vice Chair for Quality Improvement.

Dr. Geynisman has nearly 15 years of expertise in clinical research and medical oncology practice.

A graduate of the University of Pittsburgh School of Medicine, Dr. Geynisman completed his internal medicine residency at the University of Pittsburgh Medical Center and his fellowship in Hematology and Medical Oncology at the University of Chicago Medical Center. Board-certified in medical oncology, he specializes in the treatment of genitourinary malignancies.

His research interests focus on health outcomes evaluations in urologic malignancies, quality improvement in oncology, as well as new drug development for genitourinary malignancies. He is an active investigator on a number of past and ongoing clinical trials, with a particular focus in bladder and kidney cancer and has co-authored more than 170 manuscripts in peer-reviewed journals.

He serves on the NCCN guideline panel for testicular cancer and Wilms Tumor, is on ASCO's Ethics Committee and is the prior Medical Oncology editor for Urologic Oncology and current Editor-in-Chief of JNCCN.

Randy Vince Jr., MD, is a native of Baltimore, Maryland. As the oldest of four siblings, he developed a passion for athletics. He attended Towson University, where he was a Varsity Letterman in Football. At Towson University, he double majored in MB3 (Molecular biology, Biochemistry, and Bioinformatics) and Chemistry. He later attended Louisiana State University Health Sciences Center in Shreveport, where he earned his MD and subsequently completed a Virginia Commonwealth University (VCU) Health Systems residency. He developed a passion for Urologic Oncology after his grandmother's passing while he was in medical school.

After residency, Dr. Vince Jr. completed a fellowship in Urologic Oncology at the University of Michigan. While at the University of Michigan, he earned a master's degree in computational medicine and bioinformatics. He has a keen interest in using precision medicine to combat the concept of racial biology and evaluate the interaction of environmental exposures and gene expression on tumor biology. Dr. Vince Jr. recently began a new position at University Hospitals and Case Western Reserve University as an assistant professor of urology and the director of minority men's health.

Dr. Lannis Hall is Director of Radiation Oncology, Siteman Cancer Center at Barnes-Jewish St. Peters Hospital and associate professor of clinical radiation oncology at WashU Medicine. Since 2006, Dr. Hall has been a member of the Siteman Cancer Center Program to Eliminate Cancer Disparities Leadership Committee and the Leader of the Clinical Trial Outreach Core. Dr. Hall has been a member of the Disparities Elimination Advisory Committee for Washington University since 2008 and a member of the Siteman Cancer Center Senior Leadership Clinical Research Subcommittee since 2010. She is the Chair of the Cancer Oncology Conference at Barnes-Jewish St Peters and Treasurer of the Medical Executive Committee.  

She developed the clinical trials video and brochure used throughout the Siteman Cancer Center and featured on the Clinical Trials Web Page. She helped develop the Health Connections Radio Partnership with Gospel 1600 and 100.3 the Beat, delivering cancer awareness, screening/early detection, and clinical trials information for the Saint Louis Community. She is a founder of the Prostate Cancer Coalition; a group of health care providers, prostate cancer survivors, and community organizations dedicated to raising awareness about prostate cancer in high risk men. She also hosts the The Prostate Cancer Question and Answer Show, a podcast series broadcasted on Gospel 1600 and available on Spreaker, iHeart radio and iTunes. She has a special interest in prostate, breast, head and neck, and lower GI malignancies. She developed the first prostate brachytherapy program in St. Charles County in 2002 and has performed over 1100 brachytherapy procedures. 

Jan Manarite is the founder, CEO, and President of Your Prostate Cancer.help, which is a non-profit committed to helping patients and caregivers engage in Shared Decision Making by understanding their own cancer better, and asking better questions.  She has been a wife, caregiver, and widow - turned advocate, leading educational and advocacy efforts for over 20 years.  Learn more at www.YourPC.help. 

Marty Chakoian is a dedicated volunteer and experienced support group leader. Marty served as Board Chair of Us TOO and is now an active member of ZERO’s Board of Directors. His prostate cancer support group in Seattle meets twice each month; he is also a member of the NCI Council of Research Advocates and chairs the Pacific Northwest Prostate Cancer SPORE Patient Advocates Committee at the Fred Hutchenson Cancer Center.

Dr. Rayford attended the University of Kansas where he received his doctorate (Ph.D.) in Biochemistry in 1987, and his Medical Degree in 1991. He completed general surgery training at St. Luke’s Hospital in Kansas City, MO, and urology training at the University of Kansas. Dr. Rayford completed a urologic oncology fellowship at the National Institutes of Health, National Cancer Institute in Bethesda, MD. He was certified by the American Board of Urology in February, 2002.

Dr. Rayford has published extensively in the areas of prostate cancer, benign prostate hypertrophy and health disparities. He is an Associate Professor in the Department of Preventive Medicine at the University of Tennessee. He currently holds membership with the American Urology Association, American Association of Clinical Urologists, National Medical Association and R. Frank Jones Urological Society. He provides exceptional urological care to patients in East Memphis, Southaven and Holly Springs, Mississippi.

Justin Lorentz received his Masters in Genetic Counselling at McGill University in 2012. He is a certified genetic counsellor through the American Board of Genetic counselling. Justin practices clinically out the Sunnybrook Odette Cancer Centre in their Cancer Genetics and High Risk Program. He is also the lead of the Male Oncology Research and Education (MORE) Program; a registry for men with hereditary cancer. His current academic interests are in hereditary cancer with a focus on male breast cancer and prostate cancer genetics.

Alison Mayer Sachs is a distinguished leader in the field of oncology social work with decades of experience supporting cancer patients and their families. She is nationally recognized for her expertise in developing and implementing comprehensive cancer support programs that address the emotional, psychological, and practical challenges faced by those impacted by cancer. Her work has been instrumental in shaping patient-centered care models, and she has dedicated her career to fostering supportive environments that help individuals navigate their cancer journey with confidence and dignity. 

As a member of ZERO’s Medical Advisory Board, Ali brings a wealth of knowledge and compassion to her role as a moderator, ensuring that every participant in this support group feels heard, validated, and empowered. Her extensive background in counseling, patient advocacy, and program development makes her an invaluable resource for those seeking both professional guidance and community support.

Dr. Leanne Woods-Burnham is an Assistant Professor in the Department of Surgery at Morehouse School of Medicine in Atlanta, GA. Her team focuses on prostate cancer health disparities. She is a translational scientist, and her team evaluates genetic and molecular drivers of aggressive tumor biology associated with genetic ancestry. Dr. Burnham has fostered several national multidisciplinary collaborations with clinicians and pharma to conduct translational research studies and clinical trials for patients. She co-directs the Prostate Cancer Precision Prevention Program (PCP3) which leverages community partnerships to provide health education and free PSA tests to at-risk men in the greater Atlanta area. Dr. Burnham has been recognized by Cell’s #FacesofCell Twitter campaign to increase visibility of talented Black scientists, as well as The Cancer Health 25: Black Lives Matter, as a “remarkable individual breaking down racial barriers to better cancer care.” In 2025, she has been awarded “Innovator of the Year—Men’s Health” by the Atlanta Business Chronicle and “1,000 Inspiring Black Scientists in America” by Cell MENTOR.

David Diaz Sr. is a prostate cancer survivor, U.S. veteran, author, and nationally recognized patient advocate redefining how men confront serious illness. As Executive Director of The Reluctant Brotherhood, he leads a global movement built on brotherhood, resilience, and real-world leadership in the face of cancer.

Drawing from his own journey, David works with healthcare systems, advocacy organizations, and industry leaders to improve trust, engagement, and outcomes—particularly for veterans and underserved men. His work challenges outdated narratives around masculinity and illness, showing that strength and support can exist in the same space. 

Renae is a dedicated oncology professional with 17 years of experience in cancer care. She currently serves in the clinic as Chief Radiation Therapist at a Prostate Center, specializing in treating prostate cancer.

Outside of her clinical role, she is the President and Founder of Cancer Matters, a non-profit committed to providing a range of services to those affected by cancer. Her organization offers limited financial assistance in the form of gas cards, new patient orientation, support groups, patient advocacy, no-cost on-site prostate cancer screening, community outreach, and engagement activities.

Renae is wholeheartedly committed to weekly, year-round community engagement and outreach. With multiple outreach locations, Cancer Matters has developed a solidified kinship rooted in a trust-forged relationship with organizations, universities, businesses, and community leaders. Her strong belief in the importance of patient care, cancer education, and early screening opportunities to reduce late-stage cancer diagnoses is the driving force behind her efforts.

Renae's advocacy extends into statewide leadership. She serves as Chair of the Early Detection and Prevention Workgroup for the state's Arizona Cancer Coalition and is Secretary and Board Member of the Arizona Prostate Cancer Coalition, where she champions screening, education, and strategies to reduce late-stage diagnoses. Her work emphasizes prevention and early detection to improve outcomes across diverse and rural communities.

As host of Cancer Matters - The Podcast, Renae translates clinical insight and community experience into clear actionable guidance for patients, caregivers, and the public. Driven by a mission to educate, support, and inspire, Renae continues to bridge clinical care and community advocacy to make cancer resources more equitable and effective. She is committed to consistently advocating for community education, improved care, support, early detection, and prevention.

Georgia Bates is the Senior Manager of State Government Relations & Advocacy at ZERO Prostate Cancer, where she advocates for prostate cancer patients and their families in state capitols across the country. Ms. Bates leads efforts to pass state bills that make prostate cancer screening free for high-risk patients, passing bills in seven states and in Washington, D.C. She also advocates for state bills focusing on screening, diagnosis, patient access, and reducing disparities in prostate cancer care and outcomes.

Ms. Bates has advocated for patients throughout her career, most recently advocating for the Leukemia & Lymphoma Society, the Children’s Defense Fund, and mental health funding for the City of Uvalde. She has also worked for Texas Physical Therapy Association and Ensign Services, where she focused on state health policy. Ms. Bates began her career working in a Congressional Office and lobbying at the Texas Legislature, and has worked with every level of government. Georgia's connection to the cause runs deep, with two grandfathers and an uncle who triumphed over prostate cancer, and a father who is at high-risk for prostate cancer. Ms. Bates earned a B.S. from the University of Texas at Austin.

Mary Kuchma Porter, DrPH, MSN, RN is currently working as a UroOncology Nurse Navigator on a part time basis and is a volunteer support group leader for A Forum For Her. In the nurse navigator role, she provides education, care coordination, and connection to support services for patients with prostate and other cancers. Mary was asked by a patient’s wife  What’s available to help me with what I’m going through?” and reached out to Zero Prostate Cancer. More support group leaders were needed so she volunteered.

Mary is not a counselor or therapist, however hopes that understanding and compassion are what is needed to connect those who are so helpful to each other when we meet.  Mary recognizes that prostate cancer is a couple’s disease and appreciates the opportunity to provide a forum for female partners of men with prostate cancer to share their concerns, experience, and knowledge. 

Anthony “Tony” Minter Is a Retired U.S. Army Flight Paramedic; having served 20 years. He has been involved with Prostate Cancer Advocacy since 2012. As a Survivor, he made it his mission to provide support, education and awareness within his community and throughout the nation. Tony is the President and CEO of the Prostate Cancer Life Enrichment Network for Survivors & Caregivers, and a Consumer Advocate and Mentor for ZERO Prostate Cancer. He is also a past member of the Board of Directors of the South Carolina Cancer Alliance. He was recently selected to serve as the Patient Advocacy Liaison (PAL) for the Americal Urological Association. He serves on the Executive Board of the National Alliance of State Prostate Cancer Coalitions (NASPCC) and is the current treasurer. He has participated in numerous health fairs and information sessions concerning prostate cancer and has been a link between the patients, their families and their physician. He is a Certified Professional Executive Coach, specializing in Relationships, Leadership, Career and Life. Tony was also selected to be a Consumer Reviewer for the Congressionally Directed Medical Research Program (CDMRP), responsible for screening applications for research grants aimed at finding new treatment therapies, creating better detection tools and decreasing the Prostate Cancer health disparity in men of African descent. He has retired and now works tirelessly to educate men on the importance of screening and early detection. He is married to Tammie Minter and has four daughters.

Dr. Sokolova is an Assistant Professor of Medicine in Hematology and Medical ONcology at the Oregon Health and Science University School of Medicine. She specializes in caring for men with prostate cancer. She chose oncology because she values the special connection she has with her patients. She is honored to carry the responsibility of walking hand-in-hand with her patients during the most challenging times in their lives. She approaches each patient as a whole, addressing all aspects of their health and provide access to the best treatment that makes sense for them. Her special interests are in prostate cancer genetics. She has completed Intensive Course in Cancer Genetic Risk Assessment at City of Hope and has spent time at Memorial Sloan Kettering Genetics clinic. Her research focuses on helping men with prostate cancer and those with hereditary cancer syndromes to live well.

In her spare time, Dr. Sokolova and her husband enjoy spending time with their daughter and two cats. Dr. Sokolova also enjoys hosting family and friends, gardening and doing yoga.

Dr. Tosoian specializes in the early diagnosis and management of urologic cancers. In addition to his role as a clinician and surgeon, he is a recognized leader in clinical and translational prostate cancer research. His early research demonstrated the safety of monitoring lower-risk prostate cancers on active surveillance, allowing appropriately selected patients to delay or avoid treatment altogether. His ongoing research has led to the development of new, non-invasive tools to guide cancer diagnosis and management. Dr. Tosoian leads the Prostate Cancer Risk Clinic, a clinical program for informed early screening in patients with a strong family history or known genetic mutation associated with prostate cancer. 

Dr. Jacob Ark is a board-certified urologist with Urology of St. Louis, practicing primarily in Fairview Heights, Illinois and St. Louis, Missouri. A significant focus of his practice is the care of men with prostate cancer, with particular expertise in advanced prostate cancer, including biochemical recurrence and metastatic disease. His urologic training at Vanderbilt University Medical Center included uncommonly deep exposure to the management of Advanced Prostate Cancer. Since joining Urology of St. Louis in 2018, he has grown the largest advanced prostate cancer practice within the group. In a conscious effort to "treat the patient, not the problem," Dr. Ark's approach pairs clinical expertise with each patient's individual circumstances to tailor treatment plans and optimize outcomes.

Dr. Samuel L. Washington III is a urologic oncologist and Assistant Professor within the Departments of Urology and serve as the Associate Chair of Inclusive Excellence in the Department of Urology, the Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Community Outreach and Engagement Liaison, a member of the the NCCN Guidelines for Prostate Cancer Early Detection Panel, and as co-Director of the Community Outreach and Engagement Core for the UCSF Cancer Health Outcomes SPORE grant. He holds positions including Associate Chair of Inclusive Excellence in the Department of Urology, Helen Diller Family Comprehensive Cancer Center (HDFCCC) Prostate Cancer Program Community Outreach and Engagement Liaison, and served on the NCCN Guidelines for Prostate Cancer Early Detection Panel. His work and research, supported by the National Cancer Institute, Prostate Cancer Foundation, and The Movember Foundation, focuses on understanding how regional and healthcare system-related factors interact with race and ethnicity, geography, and social environment to perpetuate differences in urologic cancer management and how to develop mitigation strategies through interventions and organizational change.

He holds positions including Associate Chair of Inclusive Excellence in the Department of Urology, Helen Diller Family Comprehensive Cancer Center (HDFCCC) Prostate Cancer Program Community Outreach and Engagement Liaison, and served on the NCCN Guidelines for Prostate Cancer Early Detection Panel. His research portfolio includes efforts funded by National Cancer Institute, Prostate Cancer Foundation, and The Movember Foundation. His work includes co-investigator and co-principal investigator roles on projects funded by the Department of Defense and the Chan Zuckerberg Initiative with peer-reviewed publications in high-impact journals such as European Urology and JAMA Oncology.

Dr. Leeman is an Assistant Professor of Radiation Oncology at Harvard Medical School and serves as the director of MRI guided and adaptive radiotherapy at the Dana-Farber Brigham Cancer Center in Boston, MA. He received his AB from Harvard College and is a graduate of the Physician Scientist Training Program at the University of Pittsburgh School of Medicine. He completed his internship and residency in radiation oncology at Memorial Sloan Kettering Cancer Center in New York, NY where he served as Chief Resident. His clinical expertise lies in the areas of MRI guided radiotherapy, adaptive radiotherapy and prostate cancer. His research focuses on the application of MR imaging technology and adaptive radiotherapy for the advancement of prostate cancer treatment to improve treatment outcomes by reducing side effects of treatment and improving disease control for patients at all stages of disease.

Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and addressing important health disparities. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer.

In addition to her clinical work, Dr. Heath has led large-scale, multi-institutional, peer-reviewed research initiatives aimed at fostering collaboration across medical disciplines. Her goal is to integrate research and clinical practice, translating scientific discoveries into real-world treatments.

Dr. Heath is also committed to improving patient access to care and their experience during treatment. She emphasizes collaboration within multidisciplinary teams to achieve holistic, effective patient outcomes. Her leadership and innovative approaches have advanced the understanding and treatment of genitourinary cancers while shaping cancer care practices both nationally and internationally. Through her work, Dr. Heath continues to contribute significantly to the oncology community, with a focus on patient-centered care and health equity.

Dr. Morgans is an Associate Professor of Medicine at Harvard Medical School, a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute. As a clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and her work has been funded by grants from the Prostate Cancer Foundation , the National Comprehensive Cancer Network, and the Department of Defense. She leads multiple therapeutic and quality of life focused clinical trials for prostate cancer patients, and has participated in the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and the cardio-oncology committee of American Heart Association.  

Daniel Spratt, MD, is the Vincent K. Smith Chair of the Department of Radiation Oncology at University Hospitals Seidman Cancer Center and a Professor and Chair of Radiation Oncology at Case Western Reserve University School of Medicine.  Dr. Spratt completed his medical training at Vanderbilt University and residency training in Radiation Oncology at Memorial Sloan Kettering Cancer Center. He joined the faculty at the University of Michigan in 2015 and became the fastest tenured Professor in the University’s history in 2020. While at the University of Michigan he was the Chief of the Genitourinary Radiotherapy Program, Director of Spine Oncology, and co-Chair of the Genitourinary Clinical Research Team for the Rogel Cancer Center. Dr. Spratt joined UH Seidman Cancer Center and the Case Comprehensive Cancer Center (CCCC) in 2021 where he serves as the Chair for the Department of Radiation Oncology and co-PI of the CCCC NCTN LAPS grant. Dr. Spratt is an international expert in prostate cancer, clinical trial design, and biomarker development and validation. He serves as the Chair of the Intact Prostate Cancer Subcommittee within NRG Oncology, member of the NCCN prostate cancer guidelines committee as a special invited biomarker expert, member of the National Cancer Institute’s Genitourinary Steering Committee, and 1st Radiation Oncologist to be appointed to as a standing member to the FDA’s Oncologic Drugs Advisory Committee. He runs an NIH funded translational research team focused on the development and validation of prognostic and predictive biomarkers, has published over 400 peer-reviewed manuscripts, and has served as the principal investigator on numerous national and international clinical trials. He has mentored over 40 students, residents, fellows, and faculty, and has received numerous teaching and mentorship awards.  

Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.

Dr. McKay leads a multi-disciplinary prostate cancer clinic. Focused on delivering advanced cancer care through a coordinated team approach, this clinic enables men diagnosed with aggressive prostate cancer - either early-stage or metastatic - to see her and a team of doctors including a urologist and radiation oncologist to provide patients with highly specialized care.

As a professor in the Department of Medicine and Department of Urology, Dr. McKay instructs medical students, residents, and fellows at UC San Diego School of Medicine. Her research interests include the design and implementation of clinical trials to including novel biomarkers and therapeutic outcomes for patients with genitourinary malignancies.

She serves as principal investigator of several early phase trials in kidney and prostate cancer. As a clinical investigator, she is committed to advancements in cancer care that will improve the lives of cancer patients.

Furthermore, she is interested in understanding mechanisms of response and resistance to specific cancer therapies. Her work has appeared in peer-reviewed publications such as Nature, Lancet, Journal of Clinical Oncology, Clinical Cancer Research, and Cancer, among others.

Before joining UC San Diego Health, Dr. McKay was a medical oncologist at the Dana-Farber/Brigham and Women's Cancer Center in Boston and an assistant professor at Harvard Medical School.

Dr. McKay completed a fellowship in oncology/hematology at the Dana-Farber Cancer Institute, Harvard Medical School. She completed a residency in internal medicine at Johns Hopkins Hospital in Baltimore, Md. Dr. McKay earned her medical degree at the University of Florida College of Medicine in Gainesville, Fla.

Dr. McKay is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.

Shonta transitioned back to the non-profit sector in 2014 by joining PAF. She leads the development and execution of strategic initiatives to expand PAF’s approach to achieve health equity through community and national level partnership engagement and mobilization. These initiatives are designed to link limited income communities to resources to abate financial, logistical and social access to care barriers. She brings to this role nearly 20 years of non-profit and public sector middle and senior level experience that spans public health, women’s health and behavioral health. Additionally, she serves as the Principal Investigator on record as part of DP13-1314 CDC’s National Networks to Reduce Cancer and Tobacco Related Disparities Cooperative Agreement. In this role, she administers the SelfMade Health Network a national network focused on reducing cancer and tobacco related disparities among populations with low socio-economic characteristics. Shonta enjoys mentoring young women, golf, and watching her sons play baseball.

Dr. Tavya Benjamin, MD, is the Chief of Urology at Glen Cove Hospital, Northwell Health and Assistant Professor at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Her specialization lies in the comprehensive care and treatment of urological conditions, with a dedicated focus on prostate cancer screening and diagnosis as well as focal therapy treatments for prostate cancer.

A strong advocate for advanced and efficient diagnostic methods, Dr. Benjamin utilizes MRI-ultrasound fusion technology to enhance cancer detection rates. She also employs a transperineal approach to prostate biopsy, which significantly minimizes the risk of post-biopsy infection. Recognizing the delicate balance between effective cancer treatment and the preservation of patient quality of life, Dr. Benjamin has honed her expertise in focal therapy for prostate cancer, aiming to reduce treatment-associated side effects such as incontinence and erectile dysfunction. Beyond prostate cancer, Dr. Benjamin is well-versed in general urology conditions such as kidney stones, difficulty or too frequent urinating, and blood in the urine. 

Dr. Benjamin's decision to practice medicine was deeply influenced by her passion for improving others' health and wellbeing. "Urology provides a compelling mix of surgical and medical care," Dr. Benjamin reflects, "and this, along with the opportunity to establish lasting patient relationships, was a deciding factor for me." After receiving her medical degree from the University of Central Florida, College of Medicine, she pursued her residency at The Smith Institute for Urology - Zucker School of Medicine at Hofstra/Northwell. Further expanding her expertise, Dr. Benjamin completed a fellowship in Interventional Urology at Lenox Hill Hospital, Northwell Health. 

Donna Hollister saw the need for patient support and advocacy as a sign to start a prostate cancer support group in 1993. This group continues to grow and has been meeting for 30 years. Hollister is an extremely knowledgeable urology-certified registered nurse and is always the first to lend a hand when needed. She has coordinated the Blue Ribbon prostate cancer walks/runs in Traverse City, MI for the past 12 years and  was the recipient of the Edward C. Kaps HOPE Award in 2023. Donna  serves her support group as a knowledge bank of new break-throughs in prostate cancer treatment, a supportive friend and healthcare provider, and someone just to listen,

Tina Lamonde, RN, OCN, is a Genitourinary Oncology Nurse Navigator in Traverse City, Michigan, with over 15 years of oncology nursing experience. A passionate advocate, she has served as a ZERO prostate cancer support group leader since 2019, empowering patients and families through education, support, and shared experiences. Tina actively promotes prostate cancer awareness, early detection, and healthcare advocacy in her community and on a national level, working to improve outcomes and quality of life for those affected by the disease.

Brandy is a dedicated advocate for prostate cancer awareness and support, as her husband, Leo, was diagnosed with the disease in 2022. She is a strong supporter of ZERO Prostate Cancer and participated in Hill Day during the organization's 2024 Summit.

In addition to her work with ZERO, Brandy is the co-founder of Nunes Partners and is a dynamic and innovative Alternative Health Specialist. She also serves as President of the Board of Directors for Sue's Gift, a nonprofit that provides support and resources to women across Colorado who have been diagnosed with gynecologic cancer, and on the Board of Directors for CashForCare, a grassroots movement and directory for cash-pay friendly healthcare providers. Her exceptional contributions to her community and industry have earned her the Southern Colorado Remarkable Women award from Fox21 and Nexstar Media.

Diagnosed with prostate cancer in August 2022, Leo is a strong advocate for ZERO Prostate Cancer and participated in Hill Day during the organization's 2024 Summit. He has a deep personal understanding of the importance of accessible and affordable health care, which fueled him to be the founder of Nunes Partners, a leading agency specializing in alternative health care solutions for businesses.

In addition to his work as an employee benefits advisor, Leo is dedicated to giving back to the community. He plans to establish a nonprofit organization aimed at providing resources and education to men diagnosed with prostate cancer, drawing upon his own experience to support others facing similar challenges. Leo is also He serves on the Board of Directors for CashForCare, a grassroots movement and directory for cash-pay friendly healthcare providers and price transparency, where he contributes his expertise in advocating for transparency and affordability in the healthcare industry.

Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and addressing important health disparities. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer.

In addition to her clinical work, Dr. Heath has led large-scale, multi-institutional, peer-reviewed research initiatives aimed at fostering collaboration across medical disciplines. Her goal is to integrate research and clinical practice, translating scientific discoveries into real-world treatments.

Dr. Heath is also committed to improving patient access to care and their experience during treatment. She emphasizes collaboration within multidisciplinary teams to achieve holistic, effective patient outcomes. Her leadership and innovative approaches have advanced the understanding and treatment of genitourinary cancers while shaping cancer care practices both nationally and internationally. Through her work, Dr. Heath continues to contribute significantly to the oncology community, with a focus on patient-centered care and health equity.

Leslie J. Waltke, PT, DPT is a physical therapist with a clinical mastery in cancer rehabilitation and a provider of world class cancer rehabilitation program development consulting and continuing education. Since earning her degree in Physical Therapy from the University of Wisconsin in 1988, Dr. Waltke has dedicated most of her career solely to treating the cardiopulmonary, musculoskeletal, integumentary and functional needs of persons during and after treatment for cancer. Over the past decades Dr. Waltke has cared for thousands of people with cancer and has a following of beloved patients. She is respected nationally and internationally as an oncology physical therapist, cancer rehabilitation key opinion leader,

author, educator and consultant. Since 2005 Dr. Waltke has been the Cancer Rehabilitation Coordinator for Aurora Health Care, one of

the United States’ largest CoC and NAPBC accredited cancer programs and proud holder of the rare Commission on Cancer “Outstanding Achievement Award.” Her role, in addition to treating patients with cancer, includes cancer rehabilitation program development, program integration, education and training, and best practice and clinical standards development.

A gifted and impassioned speaker, Dr. Waltke teaches and lectures throughout the world with the Waltke Cancer Rehabilitation Academy to rehab professionals, universities, medical and oncology providers, cancer organizations as well as cancer patients and survivors. She spoke at the 2014 China Cancer Congress and the 2015 and 2017 World Cancer Congresses. In 2022 she worked with the World Health Organization to standardize oncologic rehabilitation interventions. Dr. Waltke holds a certificate in Online Education from the University of Wisconsin, is a former Board Member of the Oncology Section of the American Physical Therapy Association, an APTA Credentialed Clinical Instructor, on the Specialization Academy of Content Experts and a is a founding and current board member of ABCD, Inc. (After Breast Cancer Diagnosis). Honors include the “2014 Article of the Year Award” from the Journal of Patient-Centered Research and Reviews, the 2015 Academic Excellence

and Leadership Award from Rosalind Franklin University of Medicine and Science, and the 2015 Physical Medicine and Rehabilitation Education Recognition scholarship. Dr. Waltke is a member of ASCO and ACE, the Association of Cancer Executives. Dr. Waltke’s drive and vision to make the world better for people facing illness led her to OneVillage, where she is honored to serve as Chief Wellness Officer.

Stacey A. Kenfield, ScD received her Bachelor of Science from UCLA in Physiological Science, followed by a Master of Science in Epidemiology, a Doctor of Science in Epidemiology, and a post-doctoral fellowship, all completed at the Harvard T.H. Chan School of Public Health. She continues to lead the Harvard-based Health Professionals Follow-up Study (HPFS) prostate cancer clinical follow-up of more than 7,500 men with prostate cancer since assuming this role in 2005. These data are used to identify factors that may improve prognosis and quality of life. She has worked in cancer epidemiology for the past 10 years and received a Prostate Cancer Foundation Young Investigator Award in 2012. She was recently appointed as the Helen Diller Family Chair in Population Science for Urologic Cancer in 2016.

Meredith Morgan is a board-certified acute care nurse practitioner currently working in the Urologic Oncology Clinic at the Rogel Cancer Center in Ann Arbor. She is also an adjunct faculty clinical instructor at the University of Michigan School of Nursing. She leads lectures on prostate cancer for new oncology nurses at the University of Michigan and regularly precepts nurse practitioner students. Her current practice includes prostate cancer survivorship and advanced prostate cancer. 

She is also active in prostate cancer clinical trials. She has previously worked with prostate cancer patients at Vanderbilt University Medical Center and Weill Cornell Medical College/New York-Presbyterian Hospital. Ms. Morgan has a Bachelor of Science in Psychology from the University of Georgia and a Master of Science in Nursing from Vanderbilt University. She is a member of the American Urological Association, Oncology Nursing Society, Society of Urologic Nurses and Associates, and the Michigan Council of Nurse Practitioners.

Alison Mayer Sachs is a distinguished leader in the field of oncology social work with decades of experience supporting cancer patients and their families. She is nationally recognized for her expertise in developing and implementing comprehensive cancer support programs that address the emotional, psychological, and practical challenges faced by those impacted by cancer. Her work has been instrumental in shaping patient-centered care models, and she has dedicated her career to fostering supportive environments that help individuals navigate their cancer journey with confidence and dignity. 

As a member of ZERO’s Medical Advisory Board, Ali brings a wealth of knowledge and compassion to her role as a moderator, ensuring that every participant in this support group feels heard, validated, and empowered. Her extensive background in counseling, patient advocacy, and program development makes her an invaluable resource for those seeking both professional guidance and community support.

Meredith Morgan is a board-certified acute care nurse practitioner currently working in the Urologic Oncology Clinic at the Rogel Cancer Center in Ann Arbor. She is also an adjunct faculty clinical instructor at the University of Michigan School of Nursing. She leads lectures on prostate cancer for new oncology nurses at the University of Michigan and regularly precepts nurse practitioner students. Her current practice includes prostate cancer survivorship and advanced prostate cancer. 

She is also active in prostate cancer clinical trials. She has previously worked with prostate cancer patients at Vanderbilt University Medical Center and Weill Cornell Medical College/New York-Presbyterian Hospital. Ms. Morgan has a Bachelor of Science in Psychology from the University of Georgia and a Master of Science in Nursing from Vanderbilt University. She is a member of the American Urological Association, Oncology Nursing Society, Society of Urologic Nurses and Associates, and the Michigan Council of Nurse Practitioners.

Dr. Abhinav Khanna is a Urologic Oncologist and Robotic Surgeon at Mayo Clinic. Dr. Khanna graduated with Alpha Omega Alpha Honors from Baylor College of Medicine. He completed Urology Residency at Cleveland Clinic, one of the top-ranked urology residency programs in the nation. Dr. Khanna completed specialized fellowship training in Urologic Oncology at Mayo Clinic. As a Urologic Oncologist, he specializes in prostate cancer, kidney cancer, and bladder cancer. Dr. Khanna has expertise in robotic surgery for urologic cancer, including nerve-sparing robotic prostatectomy, complex robotic partial nephrectomy, and fully robotic radical cystectomy with intracorporeal urinary diversion. His research focuses on developing and implementing artificial intelligence tools to enhance the diagnosis and treatment of urologic cancers. He serves as the Medical Director of the inpatient urology practice at Mayo Clinic Rochester Methodist Hospital, and is also the Fellowship Director of the Grainger Research Fellowship in Urology. His practice philosophy focuses on providing compassionate and empathetic care to each individual patient, and he has been recognized as one of the top performing physicians at Mayo Clinic for Patient Experience.

Hi, my name is Sam Jolley, PA‑C, and I work with Minnesota Urology in men’s health, with a particular focus on prostate cancer recovery. I’m originally from South Dakota and earned my Master’s degree in Physician Assistant Studies from the University of South Dakota in 2019. I moved to Minneapolis in July of 2025. In my practice, I work closely with patients after prostate cancer surgery and radiation treatment, helping them through recovery—particularly managing erectile dysfunction and stress urinary incontinence following prostatectomy.

The Rev. Leroy Miles combines faith leadership with public health advocacy. As Associate Pastor for Pastoral Care and Counseling at Enon Tabernacle Baptist Church in Philadelphia, he has developed ministries addressing mental health, HIV/AIDS, and addiction, and recently launched a doula program to address Black maternal health disparities.

He serves on the board of Nephcure, supporting research and awareness for rare kidney disease, and is a consultant specializing in community engagement strategies. A certified anger management educator and graduate of the FBI Citizens Academy, his commitment to service also includes a chaplaincy internship at Children's Hospital of Philadelphia (CHOP) and leading COVID-19 testing and vaccination efforts.

Rev. Miles is also an avid cyclist, martial arts black belt, and endurance event competitor.

Dr. Imholte received a Ph.D. in clinical human sexuality (2017) and a master's in human sexuality education (2010) from Widener University. Prior to attending Widener University, Shelley graduated with a master's degree in clinical social work (2007) from the University of Texas at Austin. For over a decade, Dr. Imholte has offered specialized sexuality whole-person psychotherapy services as the owner and operator of Sexual Life Improvement, Inc., located in Austin, Texas. Shelley is proud to be a volunteer support professional with UsToo for years and anticipates continuing her professional support for Zero, More information about Dr. Imholte can be found at www.sexuallifeimprovement.com .

Yadira Montoya’s work focuses on advancing health equity and racial justice. She has over fifteen years of experience across multiple sectors, including academia, non-profit, and philanthropy. In 2019, she was recognized as a Culture of Health Leader by the Robert Wood Johnson Foundation for her leadership in community efforts that improve aging equity and the health and wellbeing of Latinx dementia family caregivers.

Prior to joining the National Alliance for Caregiving, Yadira served as a Program Officer at the Lloyd A. Fry Foundation. In this role, she oversaw the Foundation’s health portfolio and worked to increase access to primary care and reducing health care disparities for Chicago’s low-income residents. Prior to Fry, Yadira was a Research Scientist at NORC at the University of Chicago where she led and supported a broad range of research studies focused aging, public health, and participatory methods for clients in the nonprofit, government, and philanthropic sectors.

Yadira plays a leadership role in many Chicago-based aging and caregiving organization. She is a founding member of La BROCHA an innovative community arts program for Latinx older adults, especially individuals with dementia and Parkinson’s disease, living in disinvested communities. She currently sits on several boards and committees, including the Alzheimer’s Coalition for Advocacy, Research, and Education and Solutions for Care.

Yadira earned her Bachelor’s in Community Health and Master of Science in Public Health from the University of Illinois at Urbana-Champaign.

Ahmed Eldefrawy, M.D., is a urologic surgical oncologist at Miami Cancer Institute. Dr. Eldefrawy specializes in treating cancers of the male reproductive organs and male and female urinary tract, including bladder, kidney, testicular adrenal and prostate cancers. He is fluent in English and Arabic. Dr. Eldefrawy joined Miami Cancer Institute from San Diego, where he served as a urologic oncology fellow at the University of California San Diego School of Medicine.His research has been featured in a number of peer-reviewed publications, including Urology, European Urology and Urologic Oncology. He is a member of the American Urological Association and Society of Urologic Oncology and serves as a reviewer for several urology journals, including the Journal of Urology.In addition to providing evidence-based care, Dr. Eldefrawy is mindful of the emotional impact of a cancer diagnosis. His goal is to be available and supportive to his patients, while keeping them informed at all times. When he is not treating patients, Dr. Eldefrawy enjoys tennis, basketball, hiking and travel.

Donna Hollister saw the need for patient support and advocacy as a sign to start a prostate cancer support group in 1993. This group continues to grow and has been meeting for 30 years. Hollister is an extremely knowledgeable urology-certified registered nurse and is always the first to lend a hand when needed. She has coordinated the Blue Ribbon prostate cancer walks/runs in Traverse City, MI for the past 12 years and  was the recipient of the Edward C. Kaps HOPE Award in 2023. Donna  serves her support group as a knowledge bank of new break-throughs in prostate cancer treatment, a supportive friend and healthcare provider, and someone just to listen,

Tina Lamonde, RN, OCN, is a Genitourinary Oncology Nurse Navigator in Traverse City, Michigan, with over 15 years of oncology nursing experience. A passionate advocate, she has served as a ZERO prostate cancer support group leader since 2019, empowering patients and families through education, support, and shared experiences. Tina actively promotes prostate cancer awareness, early detection, and healthcare advocacy in her community and on a national level, working to improve outcomes and quality of life for those affected by the disease.